Pneumococcal
New findings in pneumococcal described from the United States
Published in Vaccine Weekly, October 11th, 2006
Study 1: Adhering to current polysaccharide vaccine recommendations for adults would prevent a significant number of cases of invasive pneumococcal disease.
According to a study from the U.S. Centers for Disease Control and Prevention in Ethiopia, "To prevent Streptococcus pneumoniae infection among persons at highest risk for invasive pneumococcal disease (IPD), the pneumococcal polysaccharide vaccine (PPV) is currently recommended for persons {{>=}}65 years old and persons 2-64 years old with certain underlying conditions. Policymakers have considered expanding...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-10-11)
More Articles from Vaccine Weekly
- Alzheimer Disease Vaccine
Immunization with amyloid-beta using GM-CSF and IL-4 reduces amyloid burden - Ebola Vaccine
Ebola virus-like particles from insect cells induce neutralizing antibodies - SARS Vaccine
Highly attenuated vaccinia virus strain protects against SARS - Tuberculosis Vaccine
Mycobacterium tuberculosis antigen was expressed to study its immunoprophylactic potential - Vaccine Development
Vaccines based on flaviviruses that are defective in replication have been developed - Alzheimer Disease Vaccine
Abeta-specific T cells reverse cognitive decline and synaptic loss in Alzheimer disease - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
